Skip to content

application of wearable intelligence electrocardiogram monitoring device in arrhythmic syncope

application of wearable intelligence electrocardiogram monitoring device in arrhythmic syncope

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027041
Enrollment
Unknown
Registered
2019-10-29
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arryhthmic syncope

Interventions

Case series:Nil

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Occurrence 1 times or more than 1 times syncope (no gender limitation); 2. Aged 18 to 70 years old.

Exclusion criteria

Exclusion criteria: 1. patients with the history of ischemic cerebral stroke, cerebral hemorrhage , cerebral tumor or other central nerve system diseases; 2. patients with valvular heart diseases; 3. patients with left atrium mucus tumor; 4. patients with hypertrophic obstructive cardiomyopathy; 5. patients with left ventricular ejection fraction less 40%; 6. moderate or severe anemia; 7. patients with severe lung diseases (i.g. chronic obstructive pulmonary disease , destroyed lungpulmonary embolism); 8. severe liver failure or renal failure( alanine aminotransferase or bilirubin more than 3 upper limit value, creatinine clearance rate less than 30ml/min); 9. severe psychological disease; 10. low quality of electrocardiography; 11. Not be able to sign informed consent.

Design outcomes

Primary

MeasureTime frame
arrhythmic syncope diagnostic rate;

Secondary

MeasureTime frame
arrhythmic syncope recurrence rate;

Contacts

Public ContactZhao Liqun

Shanghai General Hospital

zhaoliq8570@hotmail.com+86 13482528734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026